{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:20:28Z","timestamp":1757614828963,"version":"3.44.0"},"reference-count":40,"publisher":"ARAN Ediciones","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutr Hosp"],"published-print":{"date-parts":[[2025]]},"DOI":"10.20960\/nh.05519","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T09:37:56Z","timestamp":1757065076000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of the Chinese Visceral Adiposity Index for disease activity and vedolizumab response in ulcerative colitis"],"prefix":"10.20960","author":[{"given":"Qunying","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaojiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minlihu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8588","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet 2023;402:571-84.","DOI":"10.1016\/S0140-6736(23)00966-2"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2017;390:2769-78.","DOI":"10.1016\/S0140-6736(17)32448-0"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013;145:158-65.e2.","DOI":"10.1053\/j.gastro.2013.04.007"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Gros B, Kaplan GG. Ulcerative Colitis in Adults: A Review. JAMA 2023;330:951-65.","DOI":"10.1001\/jama.2023.15389"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2013;369:699-710.","DOI":"10.1056\/NEJMoa1215734"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Gros B, Ross H, Nwabueze M, Constantine-Cooke N, Derikx L, Lyons M, et al. Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis. Therap Adv Gastroenterol 2024;17:17562848241258372.","DOI":"10.1177\/17562848241258372"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Karaskova E, Velganova-Veghova M, Geryk M, Foltenova H, Kucerova V, Karasek D. Role of Adipose Tissue in Inflammatory Bowel Disease. Int J Mol Sci 2021;22:4226.","DOI":"10.3390\/ijms22084226"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Eder P, Adler M, Dobrowolska A, Kamhieh-Milz J, Witowski J. The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease. Cells 2019;8:628.","DOI":"10.3390\/cells8060628"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Graffy PM, Pickhardt PJ. Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD. Br J Radiol 2016;89:20151024.","DOI":"10.1259\/bjr.20151024"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 2010;33:920-2.","DOI":"10.2337\/dc09-1825"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Thomas DM, Bredlau C, Bosy-Westphal A, Mueller M, Shen W, Gallagher D, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity (Silver Spring) 2013;21:2264-71.","DOI":"10.1002\/oby.20408"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One 2012;7:e39504.","DOI":"10.1371\/journal.pone.0039504"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Kahn HS. The \"lipid accumulation product\" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005;5:26.","DOI":"10.1186\/1471-2261-5-26"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Xia MF, Chen Y, Lin HD, Ma H, Li XM, Aleteng Q, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep 2016;6:38214.","DOI":"10.1038\/srep38214"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Tang M, Wei XH, Cao H, Zhen Q, Liu F, Wang YF, et al. Association between Chinese visceral adiposity index and metabolic-associated fatty liver disease in Chinese adults with type 2 diabetes mellitus. Front Endocrinol (Lausanne) 2022;13:935980.","DOI":"10.3389\/fendo.2022.935980"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Pan L, Xu Q, Liu J, Gao Y, Li J, Peng H, et al. Dose-response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese. Front Endocrinol (Lausanne) 2022;13:959860.","DOI":"10.3389\/fendo.2022.959860"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Tang N, Chen H, Chen R, Tang W, Zhang H. Combination of serological biomarkers and clinical features to predict mucosal healing in Crohn's disease: a multicenter cohort study. BMC Gastroenterol 2022;22:229.","DOI":"10.1186\/s12876-022-02304-y"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Langley BO, Guedry SE, Goldenberg JZ, Hanes DA, Beardsley JA, Ryan JJ. Inflammatory Bowel Disease and Neutrophil-Lymphocyte Ratio: A Systematic Scoping Review. J Clin Med 2021;10:4219.","DOI":"10.3390\/jcm10184219"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Lee JW, Woo D, Kim KO, Kim ES, Kim SK, Lee HS, et al. Deep learning model using stool pictures for predicting endoscopic mucosal inflammation in patients with ulcerative colitis. Am J Gastroenterol 2025;120(1):213-24.","DOI":"10.14309\/ajg.0000000000002978"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Swanson G, Behara R, Braun R, Keshavarzian A. Diagnostic medical radiation in inflammatory bowel disease: how to limit risk and maximize benefit. Inflamm Bowel Dis 2013;19:2501-8.","DOI":"10.1097\/MIB.0b013e31828dc6b6"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"\u015al\u00f3sarz D, Poniewierka E, Neubauer K, Kempi\u0144ski R. Ultrasound Elastography in the Assessment of the Intestinal Changes in Inflammatory Bowel Disease-Systematic Review. J Clin Med 2021;10:4044.","DOI":"10.3390\/jcm10184044"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Minordi LM, Bevere A, Papa A, Larosa L, Manfredi R. CT and MRI Evaluations in Crohn's Complications: A Guide for the Radiologist. Acad Radiol 2022;29:1206-27.","DOI":"10.1016\/j.acra.2021.07.025"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Bojarski C, Waldner M, Rath T, Sch\u00fcrmann S, Neurath MF, Atreya R, et al. Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy. Front Med (Lausanne) 2021;8:655404.","DOI":"10.3389\/fmed.2021.655404"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Nardo GD, Esposito G, Ziparo C, Micheli F, Masoni L, Villa MP, et al. Enteroscopy in children and adults with inflammatory bowel disease. World J Gastroenterol 2020;26:5944-58.","DOI":"10.3748\/wjg.v26.i39.5944"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Mosli MH, Zou G, Garg SK, Feagan SG, MacDonald JK, Chande N, et al. C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2015;110:802-19; quiz 820.","DOI":"10.1038\/ajg.2015.120"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Bryant RV, Schultz CG, Ooi S, Goess C, Costello SP, Vincent AD, et al. Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life. Inflamm Bowel Dis 2019;25:592-600.","DOI":"10.1093\/ibd\/izy278"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Thiberge C, Charpentier C, Gillibert A, Modzelewski R, Dacher JN, Savoye G, et al. Lower Subcutaneous or Visceral Adiposity Assessed by Abdominal Computed Tomography Could Predict Adverse Outcome in Patients With Crohn's Disease. J Crohns Colitis 2018;12:1429-37.","DOI":"10.1093\/ecco-jcc\/jjy124"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Yadav DP, Kedia S, Madhusudhan KS, Bopanna S, Goyal S, Jain S, et al. Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration. Can J Gastroenterol Hepatol 2017;2017:1215035.","DOI":"10.1155\/2017\/1215035"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Sehgal P, Su S, Zech J, Nobel Y, Luk L, Economou I, et al. Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not. Inflamm Bowel Dis 2024;30:594-601.","DOI":"10.1093\/ibd\/izad111"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Li Y, Yu D, Yang Y, Cheng X, Piao W, Guo Q, et al. Comparison of Several Adiposity Indexes in Predicting Hypertension among Chinese Adults: Data from China Nutrition and Health Surveillance (2015-2017). Nutrients 2023;15:2146.","DOI":"10.3390\/nu15092146"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Je Y, Han K, Chun J, Kim Y, Kim JH, Hoon Youn Y, et al. Association of Waist Circumference with the Risk of Inflammatory Bowel Disease: a Nationwide Cohort Study of 10 Million Individuals in Korea. J Crohns Colitis 2023;17:681-92.","DOI":"10.1093\/ecco-jcc\/jjac193"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Pasanta D, Htun KT, Pan J, Tungjai M, Kaewjaeng S, Chancharunee S, et al. Waist Circumference and BMI Are Strongly Correlated with MRI-Derived Fat Compartments in Young Adults. Life (Basel) 2021;11:643.","DOI":"10.3390\/life11070643"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Yarur AJ, Bruss A, Moosreiner A, Beniwal-Patel P, Nunez L, Berens B, et al. Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study. Gastroenterology 2023;165:963-75.e5.","DOI":"10.1053\/j.gastro.2023.06.036"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Morshedzadeh N, Shahrokh S, Aghdaei HA, Amin Pourhoseingholi M, Chaleshi V, Hekmatdoost A, et al. Effects of flaxseed and flaxseed oil supplement on serum levels of inflammatory markers, metabolic parameters and severity of disease in patients with ulcerative colitis. Complement Ther Med 2019;46:36-43.","DOI":"10.1016\/j.ctim.2019.07.012"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Deurenberg P, Deurenberg-Yap M, Guricci S. Asians are different from Caucasians and from each other in their body mass index\/body fat per cent relationship. Obes Rev 2002;3:141-6.","DOI":"10.1046\/j.1467-789X.2002.00065.x"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Nishida C, Ko GT, Kumanyika S. Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr 2010;64:2-5.","DOI":"10.1038\/ejcn.2009.139"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Koutroumpakis E, Ramos-Rivers C, Regueiro M, Hashash JG, Barrie A, Swoger J, et al. Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease. Dig Dis Sci 2016;61:865-71.","DOI":"10.1007\/s10620-015-3932-1"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Huang K, Liu J, Xia W, Tian C, Yao L, Cao Q, et al. Effectiveness and safety of vedolizumab for ulcerative colitis: a single-center retrospective real-world study in China. Front Pharmacol 2023;14:1188751.","DOI":"10.3389\/fphar.2023.1188751"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Kim J, Yoon H, Kim N, Lee KM, Jung SA, Choi CH, et al. Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort Study. Inflamm Bowel Dis 2021;27:1931-41.","DOI":"10.1093\/ibd\/izaa361"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Gu P, Chhabra A, Chittajallu P, Chang C, Mendez D, Gilman A, et al. Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy. Inflamm Bowel Dis 2022;28:657-66.","DOI":"10.1093\/ibd\/izab167"}],"container-title":["Nutrici\u00f3n Hospitalaria"],"original-title":[],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T09:38:16Z","timestamp":1757065096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nutricionhospitalaria.org\/articles\/05519\/show"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":40,"URL":"https:\/\/doi.org\/10.20960\/nh.05519","relation":{},"ISSN":["1699-5198","0212-1611"],"issn-type":[{"type":"electronic","value":"1699-5198"},{"type":"print","value":"0212-1611"}],"subject":[],"published":{"date-parts":[[2025]]}}}